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Background. Stem cell and leukocyte migration during
homeostasis and inflammation is regulated by a number of
chemokines. Stromal cell–derived factor-1 (SDF-1) and its
receptor CXCR4 are important mediators of leukocyte home-
ostasis. The postischemic kidney has been shown to recruit dif-
ferent leukocyte populations, including bone marrow–derived
stem cells. Therefore, we investigated the SDF-1/CXCR4 sys-
tem in the kidney after ischemic acute renal failure (ARF).
Methods. We used immunohistochemistry, in situ hy-
bridization, enzyme-linked immunosorbent assay (ELISA)
and real-time reverse transcription-polymerase chain reaction
(RT-PCR) to detect SDF-1 and CXCR4 in the normal kidney
and the kidney after ischemia/reperfusion (I/R) ARF. Mobi-
lization was assessed by flow cytometry for CD34 and colony
assays.
Results. We show that SDF-1 is expressed in the normal
mouse kidney and tubular cells express CXCR4. SDF-1 ex-
pression in the kidney increases after I/R induced ARF and
decreases in the bone marrow, thereby reversing the normal gra-
dient between bone marrow and the periphery. This causes mo-
bilization of CD34-positive cells into the circulation and their
subsequent homing to the kidney with ARF. In vitro and in
vivo chemotaxis of bone marrow cells toward damaged kidney
epithelium is reversibly inhibited by anti-CXCR4 antibodies.
Conclusion. Our data show that renal SDF-1 is a currently
unrecognized mediator of homing to and migration of CXCR4
expressing cells in the injured kidney. Because certain cells that
express CXCR4 may have renoprotective effects, our results
suggest that SDF-1 may be a major signal involved in kidney
repair.
Stem cell and leukocyte migration during homeostasis,
inflammation, and tissue damage is a complicated and
highly regulated process coordinated by a large number
of growth factors, cytokines, and chemokines, all of which
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are derived from normal or damaged tissue or from in-
flammatory cells infiltrating such tissues [1]. Chemokines
are important in leukocyte homeostasis and inflamma-
tion and exert a number of critical functions such as
providing directional signals for leukocyte migration, ac-
tivation of leukocytes, regulation of hematopoiesis and
also angiogenesis [1]. Receptors for chemokines are ex-
pressed on leukocytes in a specific manner; however,
there is some redundancy in function and a number of
chemokines are known to be promiscuous in terms of
their receptor binding capacity. Unlike other chemokines,
stromal cell–derived factor-1 (SDF-1) is unique in that it
binds only to its receptor, CXCR4, and its importance
in hematopoiesis, cardiac and neuronal development is
furthermore underscored by the fetal lethality of either
CXCR4 or SDF-1 knockout mice [2]. Contrary to the
selective induction of most chemokines by certain stim-
uli, SDF-1 is constitutively expressed by most organs, al-
though it is known that an up-regulation of its expression
takes place after injury or DNA damage [3, 4].
Expression of SDF-1 in the kidney has so far only been
shown in the developing kidney [5], and there is not much
knowledge about its role in the adult or injured kidney.
There is evidence that SDF-1 is a major factor both in
hematopoietic stem cell (HSC) mobilization and HSC
homing to the bone marrow [6]. However, SDF-1 is not
only a major factor for HSC migration, it has also been
shown to be involved in metastasizing of rhabdomyosar-
coma, breast cancer, prostate cancer, and neuroblastoma
[7–9], as well as in attracting bone marrow–derived fi-
broblasts to bleomycin-damaged lung tissue in an animal
model of pulmonary fibrosis [10].
SDF-1 is expressed as two different splice variants,
SDF-1a and SDF-1b , the latter having four additional
amino acid residues at the carboxy terminus [11]. Al-
though it has been stated that there is no functional dif-
ference between those two isoforms [12], Stumm et al
[13] showed that endothelial SDF-1b controls cerebral
infiltration by leukocytes after ischemia, while the up-
regulation of the neuronal SDF-1a/CXCR4 system con-
tributes to neuronal plasticity and repair.
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There is currently a significant lack of knowledge about
the involvement of the SDF-1/CXCR4 system in kidney
homeostasis and disease. It has been shown recently that
following ischemic acute renal failure (ARF), the number
of circulating Sca-1+/lineage-negative cells, also a prop-
erty of HSCs, is increased [14, 15]. The precise significance
of this finding remains unknown. However, with the re-
cently discovered plasticity of HSCs [16], it is tempting to
speculate that mobilized HSCs contribute to the repair
of the injured kidney. Korbling and Estrov [17] proposed
various models of organ repair by bone marrow and circu-
lating adult stem cells. One of those models hypothesizes
that HSCs have a default pathway for hematopoietic lin-
eage differentiation, but circulating HSCs are able, under
the influence of certain stimuli derived from damaged
tissues, to overcome lineage barriers and to contribute,
through differentiation, to resident organ cells. Although
unproven, this hypothesis would give a plausible expla-
nation for recent reports of transdifferentiation of HSCs
in mice with organ damage, a phenomenon not observed
in normal mice [18].
HSCs are currently best defined using flow cytome-
try, as being negative for lineage-specific surface markers
(lineage-negative) and expressing c-kit and Sca-1 [19].
CD34, on the other hand, is a surface marker of mobi-
lized HSCs [20] as well as different progenitor cell popu-
lations, including endothelial and endothelial progenitor
cells (EPCs) [21]. Since cell populations expressing CD34
have been shown to be protective in ARF [14, 22], we
chose to use CD34 as a marker in our studies.
EPCs are an important contributor to vascular repair
after ischemic damage [23]. EPCs are bone marrow–
derived and can circulate in the blood. They express
CXCR4, the receptor of SDF-1, and share characteris-
tics with HSCs (e.g., CD34 expression and the capacity to
form colonies in vitro). Different conditions such as vas-
cular trauma, cytokines and drugs are known to mobilize
EPCs from bone marrow into the circulation [24, 25], and
a reduction in the number of peripheral EPCs has been
shown to be a risk factor for vascular events [26].
We hypothesized in the present study that kidney
injury causes up-regulation of SDF-1 and subsequent
mobilization of bone marrow–derived cells, as well as
their homing to the kidney. The aim of this study was,
therefore, to investigate the expression patterns of the
SDF-1/CXCR4 system in the normal kidney and after is-
chemia/reperfusion (I/R), and its possible role in homing
of CXCR4-expressing cells to the kidney with ARF, a
response that may contribute to cellular renal repair.
METHODS
Cells and animals
FVB mice, female or male, 20 to 30 g, were used for
all experiments. All studies were approved by the insti-
tutional animal care and use committee (IACUC). Ani-
mals were housed at constant temperature with a 12-hour
dark-light cycle and had unrestricted access to a standard
diet and tap water. Bone marrow cells were harvested
from anesthetized mice by flushing femurs and tibias
with phosphate-buffered saline (PBS). Cells were passed
through a 40 lm nylon mesh (Becton Dickinson, Franklin
Lakes, NJ, USA) and centrifuged. Granulocyte deple-
tion was accomplished by density centrifugation with
Histopaque-1077 (Sigma Chemical Co., St. Louis, MO,
USA), and the mononuclear cell fraction was collected,
washed with PBS and centrifuged. For in vivo and in vitro
tracking, cells were incubated with 25 lmol/L carboxy-
fluorescein diacetate (CFDA) (Molecular Probes,
Eugene, OR, USA), a green fluorescent cell tracking dye,
for 30 minutes in Dulbecco’s modified Eagle’s medium
(DMEM) (Sigma Chemical Co.) and thoroughly washed
with PBS thereafter. Adequacy of fluorescence staining
was confirmed by microscopy before performing exper-
iments. Primary mouse kidney tubular cells were gener-
ated by mincing kidney cortices from 2-week-old animals
and digestion with collagenase I (Sigma Chemical Co.) for
1 hour at 37◦C. Cells were passed through a 40 lm nylon
mesh and seeded on collagen I–coated 6-well plates. Once
confluent and prior to use, the epithelial nature of the cells
was confirmed by cytokeratin (pan-cytokeratin antibody)
(Sigma Chemical Co.) and aquaporin-1 (AQP1) (Santa
Cruz Biotechnology, Santa Cruz, CA, USA) staining.
Kidney injury in the in vivo homing study was induced
by clamping both renal pedicles for 60 minutes under gen-
eral anesthesia with isofluorane as described earlier [27].
Adequate reflow was assured by visual inspection post
clamp removal. This ischemia time was needed in FVB
mice in order to induce severe renal insufficiency with
a mortality of about 60% on day 3. For homing studies,
kidneys were examined on day 1 after injury.
HSC mobilization in ARF
FVB mice were anaesthetized with isofluorane and
subjected to severe ARF by clamping both renal pedicles
for 60 minutes [27, 28]. In order to determine the amount
of circulating CD34-positive cells, anesthetized mice were
sacrificed at 24 hours after ARF and blood was sampled
by cardiac puncture. Mononuclear cells were isolated
with Histopaque-1077 (Sigma Chemical Co.) and stained
with biotin-conjugated rat antimouse CD34 monoclonal
antibody and Streptavidin-PE (Pharmingen, San Diego,
CA, USA) for subsequent analysis with a FACScan An-
alyzer (BD Biosciences, San Jose, CA, USA). Clono-
genic and blood forming potential of mobilized HSCs was
assessed by culture of mononuclear cells (MNCs) in
methylcellulose medium known to promote growth of
colony-forming units (CFU) cells (CFU-C). MNCs were
isolated with Histopaque and 1.5 × 104 cells were
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suspended in 2 mL of Methocult (StemCell Tech-
nologies, Vancouver, Canada). All formed colonies
(CFU-GM, CFU-G, and CFU-M) were counted collec-
tively after 12 days of incubation, thereby including both
stem as well as progenitor cell–derived colonies.
In situ hybridization
In situ hybridization for SDF-1 and CXCR4 was car-
ried out with RNA sense (negative control) and antisense
probes derived by in vitro transcription from linearized
plasmids containing mouse SDF-1 cDNA (generously
provided by Dr. Ralf Stumm, Magdeburg, Germany)
and CXCR4 cDNA (generously provided by Dr. Ohl,
Hannover, Germany), using digoxigenin-uridine triphos-
phate (UTP) (DIG) (Roche Diagnostics, Mannheim,
Germany) as label.
Kidney sections of mice with ARF with or without
prior HSC mobilization were fixed in 10% formalin for
less than 24 hours and paraffin embedded; 4 lm tissue
sections were deparaffinized with clear solvent solution
(Richard-Allan Scientific, Kalamazoo, MI, USA) and re-
hydrated with decreasing concentrations of ethanol fol-
lowed by incubation in diethyl pyrocarbonate (DEPC)-
water and PBS. After fixation in 4% paraformaldehyde,
slides were washed in PBS and endogenous peroxidase
was quenched with 1.5% H2O2 for 25 minutes. Sec-
tions were acetylated for 10 minutes with triethanolamine
and acetic anhydride and postfixed in 4% paraformalde-
hyde (PAF), followed by prehybridization (30 minutes at
42◦C). Hybridization with the riboprobe was performed
overnight at 42◦C with an empirically tested concentra-
tion of 100 to 400 ng as quantified by DIG quantifi-
cation strips (Roche Diagnostics). After hybridization,
the probe was washed off under high stringency con-
ditions at 60◦C in buffer containing 10 mmol/L dithio-
threitol (DTT) and 2 × standard sodium citrate (SSC).
The hybridized probe was detected by overlaying sec-
tions with anti-DIG-POD antibody for 2 hours in a
humidified chamber and developing the color reac-
tion with diaminobenzidine (DAB) (Vector Laborato-
ries, Burlingame, CA, USA) and a DAB enhancement
reagent. Finally, sections were covered with mounting
medium. To control for false positive and unspecific stain-
ing, hybridization with sense probes was included in all
sections. Experiments with RNAse incubation of tissue
sections showed that after RNAse treatment no signal
was detectable, thereby confirming the specificity and
RNA nature of the obtained signal.
Immunohistochemistry
Four micron sections of formalin-fixed, paraffin-
embedded tissue were deparaffinized with xylene and hy-
drated using decreasing concentrations of ethanol. The
primary antibody was a rabbit antimouse polyclonal an-
tibody to SDF-1a (eBioscience, San Diego, CA, USA).
Kidneys from control FVB mice, mice subjected to
60 minutes ARF and HSC mobilization, as well as control
ARF mice were stained for SDF-1. Control experiments
included omission of either the primary or secondary an-
tibody. All sections for SDF staining were subjected to
antigen retrieval using immersion in a 0.1 mol/L citrate
buffer (pH 6.0) for 27 minutes, followed by heating in
an electrical pressure cooker for 3 minutes. The primary
SDF antibody was applied at a dilution of 1:100. This was
sequentially followed by incubation for 30 minutes with
a streptavidin peroxidase–conjugated secondary antirab-
bit IgG antibody (Sigma Chemical Co.) at a 1:300 dilution
and with color development using DAB (Dako, Carpen-
teria, CA, USA) for 5 minutes.
Real-time polymerase chain reaction (PCR)
RNA for real-time PCR was extracted with the RNeasy
kit (Qiagen, Valencia, CA, USA), including a DNase
digestion step to exclude contaminating DNA. Reverse
transcription (RT) was performed using Moloney murine
leukemia virus (M-MLV) reverse transcriptase (Invitro-
gen, Carlsbad, CA, USA) for 60 minutes at 42◦C.
Real-time PCR with relative quantification of SDF-1
copy numbers in relation to b-actin transcripts was car-
ried out using the following primers: SDF-1 forward TGA
GGC CAG GGA AGA GTG AG; SDF-1 reverse GAC
ACA TGG CGA TGA ATG GA; b-actin forward AGA
GGG AAA TCG TGC GTG ACA; b-actin reverse CAC
TGT GTT GGC ATA GAG GTC; CXCR4 forward TCA
GTG GCT GAC CTC CTC TT; and CXCR4 reverse TTT
CAG CCA GCA GTT TCC TT.
The Smart-Cycler system (Cepheid, Sunnyvale, CA,
USA) was used to monitor real-time PCR amplification
using SYBR Green I (Molecular Probes), a nonspecific
double-stranded DNA intercalating fluorescent dye. All
reactions were carried out in a total volume of 25 lL with
TaKaRa Ex TaqTM R-PCR Version (TaKaRa Bio Inc.,
Shiga, Japan). Reaction conditions were hot start for 120
seconds at 95◦C, melting at 95◦C for 10 seconds, anneal-
ing at 63◦C for 12 seconds, and amplification at 72◦C for
15 seconds. Reading of the fluorescent product was set
to be 2◦C below the specific melting peak of the product
in order to eliminate reading of nonspecific products and
primer dimers and was performed at 85◦C for 6 seconds
after each cycle for SDF-1. Optimal annealing and melt-
ing temperatures were determined for the primers prior
to running the samples. Melting temperature analysis for
the reaction mix revealed a characteristic melting profile
with a single sharp peak at the typical melting tempera-
ture for the product. Specificity of the product was de-
termined by a melting curve and gels were run to control
for the formation of unspecific bands. Samples were run
in duplicate and the average threshold cycle (Ct) value
was used for calculations. The Ct, which is the cycle at
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which the amount of amplified gene of interest reached
a threshold above background fluorescence, was deter-
mined in order to quantitate initial starting copy amount.
Relative quantitation of SDF-1 mRNA expression was
calculated with the comparative Ct method using the fol-
lowing formula:
effC(target)/effC(b−actin) = 2(C(target)−C(b−actin))
The relative quantitation value of target, normalized
to an endogenous control b-actin gene, is expressed as
a number, which indicates the relative expression com-
pared to that gene. To avoid the possibility of ampli-
fying contaminating DNA and unspecific amplification,
the following precautions were taken: (1) a DNase-
digestion step was included in the RNA-extraction
protocol, (2) some primers were designed to include an
intron sequence inside the cDNA to be amplified, (3) re-
actions were performed with appropriate negative con-
trols (template-free controls), (4) a uniform amplification
of the products was rechecked by analyzing the melting
curves of the amplified products (dissociation graphs),
and (5) gel electrophoresis was performed to confirm
both the correct size of the amplification products and
the absence of unspecific bands, respectively.
Enzyme-linked immunosorbent assay (ELISA)
SDF-1 protein quantification in kidneys before (N =
3) and day 1 and day 3 after ARF (N = 3), bone mar-
row supernatant, and peripheral blood were carried out
by ELISA (RnD Systems, Minneapolis, MN, USA). De-
capsulated kidney tissues were minced, sonicated, lysed
with RIPA buffer [1 × PBS, 1% Nonidet P-40, 0.5%
sodium deoxylate, 0.1% sodium dodecyl sulfate (SDS)
and protease inhibitor] for cell and tissue lysis and protein
quantified by BCA protein assay reagent assay (Pierce,
Rockford, IL, USA). Bone marrow from femurs of mice
(N = 3) was flushed with 500 lL PBS and cells were spun
down. Cell fractions and supernatants were analyzed for
SDF-1. Equal protein amounts were assayed for SDF-1;
96-well plates were coated with 100 lL of SDF-1 antibody
(final concentration 1 lg/mL) and incubated overnight.
Wells were washed with 400 lL buffer (0.05% Tween 20 in
PBS) and incubated for 1 hour at room temperature with
300 lL blocking buffer [1% bovine serum albumin (BSA)
and 5% sucrose in PBS with 0.05% NaN3]. One hun-
dred microliters of sample were loaded and incubated for
2 hours at room temperature. After three washing steps,
anti-SDF-1 antibody was applied and samples were incu-
bated for 2 hours at room temperature. After washing,
horseradish peroxidase conjugate was added to the reac-
tion mixture and incubated for 20 minutes at room tem-
perature. The reaction was stopped and optical density
was determined with a microplate reader set at 450 nm.
Wavelength correction was set to 570 nm. Sample results
were calculated from a standard curve generated by dilu-
tions of a known amount of recombinant SDF-1 protein.
The SDF-1 concentration in each sample is the average
of duplicate assays.
Migration assays
In the transfilter assay, primary kidney tubular cells
from 1- to 2-week-old FVB-mice were grown to conflu-
ence in 6-well plates and were adenosine triphosphate
(ATP) depleted by incubation in glucose free medium for
30 minutes with Antimycin A 1.7 lmol/L (Sigma Chemi-
cal Co.) in which glucose was substituted by 10 mmol/L 2-
deoxy-glucose (90% ATP depletion was achieved in this
setting as determined by luminescence assays) (Sigma
Chemical Co.) (data not shown). After ATP depletion
the cells were washed twice and allowed to recover for
60 minutes in normal medium before the bone mar-
row cells were put onto the transwell filter insert. Bone
marrow MNCs (105 cells), immunomagnetically (Dynal
Biotech, Brown Deer, WI, USA) enriched CD34-positive
cells (103 cells) or bone marrow (105 cells) incubated
with CXCR4 antibody (10 lg/mL for 30 minutes) (eBio-
science) to block SDF-1 signaling were put on top of a
polycarbonate filter insert (transwell) coated with gelatin
(8 lm pore size) (Nunc, Naperville, IL, USA). After incu-
bating at 37◦C for 2 hours, cells on the top surface of the
filter were removed and cells that had migrated through
the filter to the undersurface were fixed in methanol and
stained with hematoxylin. Cell numbers of at least ten
high-power fields (40×) were counted for experimental
and control groups and the experimental groups were ex-
pressed as fold increase or decrease compared to control
groups, respectively. Results are given as the average of
three experiments.
In vivo homing studies
To determine the number of homing cells in bilater-
ally or unilaterally clamped kidneys, 106 cells of whole
bone marrow from normal mice were stained with CFDA
and injected into the tail vein immediately after 60 min-
utes of renal pedicle clamping. Animals were sacrificed
at 24 hours and kidneys were obtained for further analy-
sis. One quarter of each kidney was digested with col-
lagenase for 60 minutes at 37◦C. After centrifugation
and washing with PBS, kidney cells were resuspended
and put into a Neubauer chamber for counting. Injected
and homed cells were clearly recognizable by their bright
green CFDA staining. CFDA-positive cells as well as total
cell numbers were counted in at least two samples of the
same kidney and averaged. Bone marrow was obtained
by flushing both femurs with PBS and quantification of
homed cells was carried out by counting CFDA-positive
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cells in relation to bone marrow cells in a Neubauer cham-
ber. To determine the role of CXCR4 in the homing
of CXCR4-expressing cells to the injured kidney, bone
marrow cells were preincubated with 10 lg anti-CXCR4
blocking antibody (eBioscience) for 30 minutes and cells
were injected after washing and centrifugation. Kidney
and bone marrow were examined for CFDA-positive cells
as described above. Results are given as average of three
experiments.
Data analysis
Data are expressed as means ± SD. Differences be-
tween data means were analyzed by analysis of variance
(ANOVA) or Student t test using Prism software (Graph-
Pad, San Diego, CA, USA). A P value of less than 0.05
was considered significant.
RESULTS
SDF-1 and CXCR4 are up-regulated in postischemic
kidneys
In order to determine expression of SDF-1 and CXCR4
on a protein level in the healthy and postischemic kidney,
we subjected tissue sections from normal and ARF kid-
neys to immunohistochemical analysis. The staining for
SDF-1 in the normal kidney cortex showed a patchy pat-
tern under low magnification. Cytosol of distal tubular
cells stained with SDF-1, while most proximal tubular
cells were negative or stained only weakly (Fig. 1, upper
panel). Except for glomerular endothelial cells, glomeruli
were negative. After I/R injury, virtually all surviving cells
in cortex and outer medulla stained positive for SDF-1
(Fig. 1, lower panel) (i.e., demonstrating injury-induced
up-regulation of SDF-1). Control incubation with sec-
ondary antibody alone did not result in any staining (not
shown).
CXCR4 (fusin), the receptor of SDF-1, is expressed on
tubular cells, with more intense staining of distal tubular
compared to proximal tubular cells (Fig. 2, upper panel).
Glomeruli did not stain for CXCR4. Twenty four hours
after ARF, surviving proximal tubular cells showed in-
creased expression of CXCR4, indicating that there is
both induction of SDF-1 as well as CXCR4 after ischemic
injury (Fig. 2, lower panel).
RNA in situ hybridization shows up-regulation of SDF-1
after ischemia
To confirm the immunohistochemical results and to
identify SDF-1–producing cells, we performed RNA in
situ hybridization. All negative controls showed only min-
imal background staining, whereas sections subjected to
treatment with anti-sense probe showed clear staining
consistent with a positive hybridization signal. Staining
patterns of SDF-1 and CXCR4 by in situ hybridization
were essentially the same as those detected by immuno-
histochemistry with expression of SDF-1 mRNA mainly
in distal tubular cells and in the papillae, while glomeruli
were negative and normal proximal tubules stained rarely
and with low intensity, thus corroborating our immuno-
histochemical results (Fig. 3). In situ hybridization in
kidneys postischemic injury showed SDF-1 expression
in almost all tubule segments that were not necrotic or
apoptotic, as well as in detached tubular cells in the lu-
men (Fig. 4, upper left panel). Some cells in glomeruli
stained weakly (Fig. 4, lower left panel), while necrotic
tubule segments showed no staining, thus excluding non-
specific background staining.
Real-time quantitative PCR corroborates the observed
up-regulation of SDF-1
SDF-1 RNA levels increased significantly 2.5-fold as
early as 11/2 hours after I/R in the kidney and were in-
creased twofold at 24 hours after ARF (Fig. 5). This
response corroborates the results seen with in situ hy-
bridization. Our in vitro model of tubular injury also
showed an increase in SDF-1 expression after injury.
Specifically, a primary tubular cell monolayer subjected
to graded ATP depletion showed a 1.5-fold increase in
SDF-1 RNA expression immediately after and up to
3 hours after ATP depletion.
SDF-1 protein levels in kidney and plasma are elevated
after ARF while bone marrow levels are reduced
While normal renal cortical levels of SDF-1 were 5.5 ±
1 ng/mg protein, there was a significant increase to 10.8 ±
3.3 ng/mg protein in the cortex at 24 hours after ARF
(Fig. 6A). SDF-1 levels in whole kidney increased with-
out reaching statistical significance. At 3 days after ARF,
there was still an increase in protein levels of SDF-1 in the
whole kidney. SDF-1 levels in plasma were significantly
increased at 24 hours after ARF and remained elevated
up to day 3 (Fig. 6B). To determine if the kidney is the
main source of the SDF-1 elevation, mice were nephrec-
tomized and plasma SDF-1 levels were measured at day
1. SDF-1 plasma levels were significantly increased to the
same level as in ARF animals, caused both by accumu-
lation of SDF-1 produced by nonrenal sources as well as
absent elimination by the kidney. Clamping of only one
kidney resulted in an increase of SDF-1 in the plasma as
well. SDF-1 levels in the bone marrow supernatant were
significantly decreased after ARF (Fig. 6), thereby re-
versing the gradient from bone marrow to blood, which
is a potent stimulus for stem cell mobilization [29]. We
found that the reduced bone marrow levels are due to re-
duced production of SDF-1 by bone marrow cells (data
not shown).
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Fig. 1. Stromal cell–derived factor-1 (SDF-1) is up-regulated in acute rental failure (ARF). Immunohistochemisty of normal kidney. SDF-1 is
expressed, by immunohistochemistry, mostly by distal tubular cells in the cortex (upper panels). Twenty-four hours after induction of ARF, most
regions of the kidney cortex strongly express SDF-1 (bottom panels) (upper left panel original magnification ×10; lower left panel ×20; upper right
panel ×40; lower right panel ×40).
Fig. 2. CXCR4 is up-regulated after acute renal failure (ARF). Immunohistochemistry of normal kidney. CXCR4 is detected in a similar pattern
to that of SDF-1 seen in Fig.1 (upper panels). After induction of ARF, CXCR4 is up-regulated in the areas of kidney injury (lower panels) (left
panels, original magnification ×10; right panels ×40).
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Fig. 3. Stromal cell–derived factor-1 (SDF-1) mRNA in situ hybridization in normal kidney. Normal kidney showing strong staining mainly of distal
tubules and weak staining of remaining tubular segments (upper left panel). Glomeruli are negative for SDF-1 expression (original magnification
×20). Expression in the medulla (upper right panel). Higher magnification (lower left panel) of the same kidney (upper left panel) (original
magnification ×40). Control hybridization with sense probe (lower right panel). No nuclear counterstain was used.
Bone marrow and CD34-positive cells migrate toward
damaged kidney cells in vitro
Primary kidney tubular cells grown from 1- to 2-week-
old mice were injured by ATP depletion for 30 minutes in
serum- and glucose-free medium containing Antimycin
A and 2-deoxy glucose. This procedure led to a signif-
icant decrease of ATP levels to 10% of baseline as de-
termined by a luminescence assay (data not shown) and
increased expression of SDF-1 (see above). Bone mar-
row cells expressing CXCR4 seeded onto the top of a
transwell insert showed a significant migratory response
toward the ATP-depleted monolayer of tubular cells in
the bottom well when compared to that observed with
undamaged cells (Fig. 7). To determine the role of SDF-1
in this migratory response, the SDF-1 receptor, CXCR4,
was blocked with an anti-CXCR4 antibody, which signif-
icantly decreased cell migration toward damaged tubu-
lar cells. However, since there was still a significant
difference between CXCR4-blocked and control cell mi-
gration, it is likely that other factors besides SDF-1 are
involved in mediating this migratory response. The same
migratory response was seen when immunomagnetically
isolated CD34-positive cells were tested with this system
(data not shown).
Bone marrow cells home to the kidney in vivo
To determine the capacity of injected bone marrow
cells to home into the kidney in vivo, we developed a
homing assay as described in the Methods section. The
kidney contained an average of eight injected bone mar-
rrow cells per million cells at day 1 after ARF, whereas
the bone marrow contained three cells per million cells
(Fig. 8). After blocking the SDF-1 pathway with antibod-
ies against CXCR4, the numbers of homing cells in kidney
and bone marrow were significantly reduced to 0.6/mil-
lion cells and 0.13/million cells, respectively. This pattern
corroborates the results of the previous in vitro studies
showing the importance of the SDF-1/CXCR4 system in
chemotaxis.
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Fig. 4. Stromal cell–derived factor-1 (SDF-1) mRNA in situ hybridization in kidney after acute renal failure (ARF). Injured but surviving cells
highly express SDF-1 mRNA (left upper panel), while necrotic areas stain negative (upper right panel) (original magnification ×10; other panels
×100). Note the expression of SDF-1 in detached cells in the tubulus lumen (arrow, upper left panel). Nuclei are counterstained with hematoxylin
(original magnification in lower panels show higher magnifications ×40).
Homing is specific to the injured kidney
Unilateral clamping of the left kidney and injection
of bone marrow showed that the homing process is se-
lective for the injured organ (data not shown). The dam-
aged kidney contained the same amount of cells as seen in
bilateral clamping experiments, whereas the noninjured
kidney did not contain any cells 24 hours after the infu-
sion. Involvement of the SDF-1/CXCR4 system was also
demonstrated by the almost complete absence of homed
cells in the damaged kidney and bone marrow after block-
ing CXCR4 (Fig. 8).
ARF causes mobilization of CD34-positive cells
SDF-1 is a known stem cell and leukocyte-mobilizing
chemokine [28]. Since we showed an increase of SDF-1
plasma levels after ARF, we asked if there is an increase
in circulating CD34-positive cells during recovery from
ARF. Levels of circulating CD34-positive cells in normal
animals are 1% of leukocytes, and after ARF, there is a
significant increase (P < 0.01) to 7% of total leukocytes
(Fig. 9). These data correspond well with the increase
in SDF-1 plasma levels, although it is likely that other
factors are involved in causing the rise of peripheral cir-
culating CD34-positive cells. Paralleling the increase of
circulating peripheral blood CD34-positive cells, we de-
tected an increase of CFU-C in peripheral blood (500 lL)
after ARF. Control mice had a mean of 1.1 ± 0.5 (N =
4) CFU-C/500 lL peripheral blood and 24 hours after in-
duction of ARF this increased to a mean of 14 ± 1.6/500
lL (P < 0.05).
DISCUSSION
This study was performed because we hypothesized
that the SDF-1/CXCR4 system is important in the regula-
tion of stem and progenitor cell trafficking after ischemic
ARF. Our results demonstrate that SDF-1 is expressed
in the normal kidney and up-regulated after ARF. SDF-
1 serum levels increase after ARF while bone marrow
SDF-1 levels decrease, leading to a reversal of the normal
gradient from bone marrow to peripheral blood, in turn
resulting in mobilization of CD34-positive cells that have
colony forming ability as shown by CFU-C assay. We also
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Fig. 6. Stromal cell–derived factor-1 (SDF-1) protein levels in kidney
(A), plasma and bone marrow (B) after acute renal failure (ARF). SDF-
1 protein in the kidney cortex (A) was significantly elevated at 24 hours
after ARF compared to normal kidney levels, but not in the whole
kidney on day 1(d1) and day 3 (d3) after ARF. SDF-1 plasma levels
(B) were significantly elevated at day 1(d1) and day 3 (d3) compared to
baseline. Total nephrectomy (total nx) also led to elevated SDF-1 levels
compared to baseline. Bone marrow (BM) SDF-1 levels were reduced
after ARF compared to bone marrow baseline levels, thereby reversing
the normal bone marrow blood gradient.
show that CXCR4, the receptor for SDF-1, is expressed
on tubular cells and expression is up-regulated after is-
chemia. Because cells, such as HSCs and EPCs, that ex-
press CXCR4 may have renoprotective effects and SDF-1
is not an inflammatory but a homeostatic chemokine, our
results suggest that SDF-1 may be a currently unrecog-
nized signal involved in kidney repair.
SDF-1 is a unique chemokine being highly conserved in
mammals. It is the only chemokine necessary for embry-
onic survival, it binds to and signals exclusively through
CXCR4, and is essential for stem cell homing. Although it
has been shown to be a chemoattractant for T cells, move-
ment of T cells is concentration-dependent and there is
a selective repulsion of T-cell subpopulations at higher
levels of SDF-1, which explains the low frequency of T
cells in compartments like the bone marrow [30]. SDF-1
is known to play a key role in CD34-positive cell traffick-
ing [28], and to mediate mobilization of HSCs and pro-
genitor cells from the bone marrow by chemotaxis [28,
31]. This system is also important in the homeostasis of
a number of other leukocyte types such as lymphocytes,
monocytes, and neutrophils. Although CXCR4 and SDF-
1 are induced by hypoxia [32] or DNA damage [4], SDF-1
is primarily a homeostatic rather than an inflammatory
chemokine. This has been demonstrated in patients with
unstable angina, where SDF-1 in high concentrations has
anti-inflammatory and matrix stabilizing effects [33].
We show in the present study that the SDF-1/CXCR4
system appears activated in ARF. It stimulates CD34-
positive cell mobilization from the bone marrow as shown
by increased numbers of circulating CD34-positive cells
by FACS analysis and CFU-C, and it directs recruitment
of CXCR4 expressing bone marrow cells to the injured
kidney, as shown by in vitro and in vivo migration assays.
ARF, a common complication among hospitalized pa-
tients, is still affected with a disturbingly high mortality
rate. Treatment options are limited to largely support-
ive measures. New stem cell–based treatment approaches
have been tested, but to date there is only one report
showing that administered MSCs are of functional bene-
fit in cis-platinum–induced ARF [34]. HSCs have been
shown to contribute to the tubular cell pool [14, 15];
however, their functional impact on the severity of is-
chemic ARF and their contribution to regeneration in
this form of ARF remains to be established. Only re-
cently has the microvascular component of ARF come
to broader attention [35], and the targeting of vascular
damage seems a promising new treatment approach in
ARF. HSCs and EPCs are derived from a common pro-
genitor cell, the hemangioblast [36]. Our results show that
circulating CD34-positive cells with the capacity to form
CFU-Cs are increased after ARF and that this is medi-
ated, at least in part, by reversal of the SDF-1 gradient
from blood to bone marrow. Since EPCs are also charac-
terized by CD34 expression and high numbers of CXCR4
receptors in their cell membrane, mobilization of EPCs
and HSCs, induced by ischemic ARF, is possibly an adap-
tive response, mainly mediated by SDF-1, a response that
has the potential to support the repair of the injured kid-
ney.
There are various models for stem cell repair of dam-
aged tissues. Tissue repair is facilitated in many cases
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Fig. 7. In vitro migration assay. Bone marrow (BM) cells migrate to-
ward adenosine triphosphate (ATP)-depleted primary kidney tubular
cells. By blocking CXCR4 with an antibody, migration is significantly
reduced compared to ATP-depleted monolayers, but it remains signif-
icantly higher than compared to control experiments, suggesting that
other migration-stimulating factors are involved as well.
(e.g., liver injury or kidney tubule damage, by dediffer-
entiation, migration, proliferation and redifferentiation
of cells). However, repair is also thought to involve se-
lective recruitment of circulating stem and progenitor
cell populations. A model proposed by Anderson, Gage,
and Weissman [37] suggests that an equilibrium exists
between apoptotic cell loss and replacement of cells by
tissue intrinsic stem cells. In addition, blood-derived stem
cells of heterologous lineages are thought to contribute to
tissue repair, although to a much lower extent. In the case
of tissue damage (e.g., when apoptosis exceeds the repair
capacity of intrinsic stem cells), recruitment of circulat-
ing stem cells serves as back-up response. This response
may be mediated by the SDF-1/CXCR4 system. How-
ever, if damage is very severe, intrinsic repair capacity
will be exhausted, resulting, in turn, in disease such as ir-
reversible ARF. Our data provide evidence in support of
this model, since we demonstrate both activation of the
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Fig. 8. In vivo homing of whole bone marrow (BM) cells in kidney and
bone marrow. Intravenously injected bone marrow cells home to the
injured kidney after 24 hours as well as to the bone marrow. This hom-
ing process can be significantly inhibited compared to homing without
blocking by preincubation with a blocking antibody to CXCR4.
SDF-1/CXCR4 system in ARF as well as mobilization of
CD34-positive cells into the circulation.
Accordingly, we suggest that kidney tissue damaged by
ischemia initiates repair by extrinsic cells via up-regulated
expression of SDF-1, which, in turn, leads to the mobiliza-
tion and homing of CXCR4/CD34-positive cells. Further-
more, the concentrations of SDF-1 we found in the kidney
reach the concentration detected in the bone marrow, a
level shown to induce repulsion of T cells and thereby
having an anti-inflammatory effect [30]. However, the
mobilization of CD34-positive cells might not be ade-
quately protective in the case of severe injury. A possible
way of enhancing this chemokine response could be the
administration of SDF-1 or the enhancement of EPC mo-
bilization with sulfated polysaccharides [38].
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Fig. 9. Circulating CD34-positive cells in peripheral blood (PB) of con-
trol animals and animals with 60 minutes ischemic acute renal failure
(ARF). The number of circulating CD34-positive cells is significantly
(P < 0.0014) increased at 24 hours after induction of ARF.
We also show CXCR4 expression on tubular cells and
up-regulation after ischemia. CXCR4 has been described
in different epithelial cell populations like alveolar ep-
ithelial cells as well as colonic epithelial cells [39]. CXCR4
is up-regulated by hypoxia and has also been implicated in
cancer metastasis and leukocyte migration [40]. Hypoxic
induction of CXCR4 may be a protective mechanism,
since it was demonstrated that increased CXCR4 expres-
sion enhanced proliferation of epithelial cells by acti-
vating the mitogen-activated protein (MAP)/Erk kinase
pathway, and acceleration of angiogenesis by increas-
ing vascular endothelial growth factor (VEGF) secretion
[41]. Although it is speculative, it is possible that the in-
crease of SDF-1 expression in the kidney directly protects
the epithelial cells that have up-regulated CXCR4 by the
MAP/Erk kinase pathway as mentioned above.
Bone marrow–derived circulating EPCs participate in
the vascular regeneration after various injuries. For ex-
ample SDF-1 was observed to attract EPCs to ischemic
regions in a hind-limb injury model, a response that pre-
vented apoptosis and led to improved vasculogenesis and
neovascularization [42]. It was recently reported that fi-
broblasts, engineered to express SDF-1, and when in-
jected into ischemic cardiac tissue attract mobilized stem
cells, which in turn resulted in improved cardiac func-
tion after ischemia [43]. In kidney allografts, the extent
of replacement of donor endothelial cells lining the per-
itubular capillaries by those of the recipient is related to
the severity of concurrent vascular injury [44]. Since ARF
also has an important vascular injury component, this vas-
cular repair process might also play a role in physiologic
as well as therapeutic regeneration.
Endothelial injury, an important component of ARF,
leads to increased recruitment of inflammatory cells caus-
ing further cellular damage. Targeting this component
of the injury cascade by enhancing repair of damaged
vessel segments through mobilization of EPCs may be
a promising new treatment approach. Preliminary data
from our laboratory [abstract; Westenfelder C et al, J Am
Soc Nephrol 14:570A, 2003] and others [22] have shown
that infused, differentiated endothelial cells are renopro-
tective after ARF. Certain other stem cell populations
such as mesenchymal stem cells with endotheliogenic po-
tential are also under investigation.
Induction of SDF-1 induction after ischemia is medi-
ated by hypoxia-inducible factor-1 (HIF-1) [45], a tran-
scription factor and the central mediator of cellular
responses to hypoxic conditions. It is readily degraded
in normoxic cells and HIF-2 has been shown to be an
important mediator of adaptive responses after ischemic
ARF [46].
Ratajczak et al [47] found that there are circulating
progenitor cells for different lineages in the peripheral
blood after injury and hypothesized that these are mo-
bilized as a repair response induced by damaged organs.
They also showed an increase in SDF-1 mRNA in the kid-
ney after CCl4 induced liver and secondary kidney injury,
corroborating our present results.
Hatch et al [48] showed that SDF-1 contributes to hep-
atic oval cell activation and bone marrow stem cell re-
cruitment after liver injury. The involvement of SDF-1
as well as hepatocyte growth factor (HGF) and matrix
metalloproteinase-9 (MMP-9) in human stem cell recruit-
ment to the injured liver has also been demonstrated by
Kollet et al [49]. Taken together, these reports support
our finding that the SDF-1/CXCR4 system plays an im-
portant role after renal damage.
We have previously shown that mobilization of HSC
leads to a more severe form of ARF with higher mortality
and greater histologic damage [27]. However, the mobi-
lization regimen used in the previous study is entirely
different from the mobilization of CD34-positive cells
described here, because granulocyte-colony-stimulating
factor (G-CSF) and cyclophosphamide administration
leads to massive leukocytosis with a large increase in
circulating granulocyte numbers, a cell type that is sig-
nificantly involved in the pathogenesis of ARF. Further-
more, ARF was induced at the time when circulating
neutrophils numbers peaked. The mobilization of CD34-
positive cells, as described here, mainly takes place due
to a reversal of the SDF-1 gradient from bone marrow to
peripheral blood, which is a stimulus for mobilization of
progenitor cells [29]. Although it is known that SDF-1 can
induce leukocytosis as well [28], the time frame for this
response differs from the course of ARF in our model.
CONCLUSION
Our results describe the SDF-1/CXCR4 system in the
kidney after ischemic ARF and its role in the recruitment
and mobilization of CXCR4-positive cells. This adaptive
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response to ARF likely serves to support organ repair by
cells extrinsic to the kidney, and, if it can be therapeuti-
cally enhanced, it may prove of therapeutic utility.
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